Zkušenosti pracoviště s erlotinibem (Tarcevou) u nemocných s nemalobuněčným karcinomem plic (NSCLC)

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English The experience of the clinical center with erlotinib (Tarceva) in patients with non-small cell lung cancer (NSCLC)
Authors

TOMÍŠKOVÁ Marcela SKŘIČKOVÁ Jana KAPLANOVÁ Jana BABIČKOVÁ Lenka VAŠUTOVÁ Irena KADLEC Bohdan TURČÁNI Pavel STAŇKOVÁ Yvonne NEBESKÝ Tomáš SVOBODNÍK Adam

Year of publication 2007
Type Article in Proceedings
Conference XV. Západočesképneumoonkologické dny - Plzeň
MU Faculty or unit

Faculty of Medicine

Citation
Field Pneumology
Keywords erlotinib; non-small cell lung cancer
Description The wealth of experience the Brno Department of Pulmonary Diseases has amassed over the time treating non-small cell lung cancer with erlotinib (Tarceva)is outstanding in the Czech Republic; in order to share this experience the authors presented their results in this paper.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info